Micron stock price jumps nearly 8% as $1.8 billion Taiwan fab deal and Stifel target lift MU

Micron stock price jumps nearly 8% as $1.8 billion Taiwan fab deal and Stifel target lift MU

New York, Jan 20, 2026, 09:33 EST — Regular session

  • Micron shares surged nearly 8% in early trading, driven by investor attention on memory supply.
  • The move follows a $1.8 billion plan to buy a Taiwan fab and a new target raise from Stifel.
  • Deal approvals and the upcoming earnings report are on traders’ radar for clues about DRAM and HBM.

Micron Technology Inc (Nasdaq: MU) shares surged roughly 7.8% to $362.75 in early New York trading Tuesday, climbing $26.12 from the previous close and briefly touching $362.84. The rally came on the back of Micron’s announcement to expand capacity in Taiwan, coupled with new price-target upgrades from Wall Street analysts.

Memory’s back as a bottleneck, plain and simple. Investors aren’t just betting on growth—they’re pricing in the risk of shortages. The focus is on high-bandwidth memory, the key component for AI servers, since its supply can tighten fast and steer the whole market’s direction.

Micron announced it will acquire Powerchip Semiconductor Manufacturing Corp’s P5 fab in Tongluo, Miaoli County, Taiwan, for $1.8 billion in cash. The deal is expected to finalize by Q2 2026, pending regulatory approval. Micron aims to ramp up DRAM wafer production at the site by the second half of 2027. 1

Stifel’s Brian Chin bumped his price target on Micron to $360 from $300, maintaining a Buy rating following the acquisition news. He said he’s still “upbeat” on the tight memory market well into fiscal 2026. 2

Micron produces DRAM, the primary working memory found in servers and PCs, alongside NAND flash used in storage devices. The company also manufactures high-bandwidth memory (HBM), a stacked DRAM variant designed to sit near AI processors for faster data transfer.

A letter of intent doesn’t seal the deal, but it lays out a clear route to boosting capacity in a sector where new facilities often take years to come online. The cleanroom area at the Taiwan site is key—it’s the controlled environment essential for operating the equipment that manufactures chips.

Still, the benefits won’t show up right away. Capacity hitting in 2027 does little to ease short-term supply concerns, leaving the market vulnerable to any demand fluctuations.

Memory investors know the drill. If major cloud clients cut back spending or competitors ramp up capacity faster than anticipated, prices can drop sharply — and a stock that’s rallied this hard can lose those gains just as quickly.

Micron entered Tuesday riding a solid streak, its shares having climbed roughly 27% in 2026, per Investors.com. That kind of momentum tends to magnify the impact of any news, whether positive or slightly underwhelming. 3

Investors are now zeroing in on the Taiwan deal’s progress — from filings and regulatory hurdles to updates on the closing schedule. They’ll also watch Micron’s upcoming earnings report for clues on pricing and supply control. According to market calendars like Yahoo Finance, Micron’s next earnings call is expected around March 18. 4

Stock Market Today

Reckitt share price ends week near a one-year high as RKT investors eye special dividend and March results

Reckitt share price ends week near a one-year high as RKT investors eye special dividend and March results

7 February 2026
London, Feb 7, 2026, 08:16 GMT — Market closed. Reckitt Benckiser Group (RKT.L) shares ended Friday at 6,400 pence, down 0.2%, after touching a one-year high of 6,432 pence. About 2.6 million shares changed hands. 1 The stock is now trading through the tail-end of a chunky one-off cash return. Reckitt has set a 235 pence-a-share special dividend for Feb. 20 and is pairing it with a 24-for-25 share consolidation to keep the quoted share price and per-share metrics broadly comparable after the payout. 2 In the wider market, Britain’s FTSE 100 finished Friday up 0.6%, with gains in heavyweight
GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Apple stock slips early as tariff jitters weigh on tech; analysts point to iPhone demand
Previous Story

Apple stock slips early as tariff jitters weigh on tech; analysts point to iPhone demand

Microsoft stock price today: MSFT ticks up on Bristol Myers AI lung-cancer imaging deal
Next Story

Microsoft stock price today: MSFT ticks up on Bristol Myers AI lung-cancer imaging deal

Go toTop